medonline

Mag. Oliver Eberhardt

Beiträge von Mag. Oliver Eberhardt

Prof. Solange Peters, MD, PhD, CHUV Lausanne
Breakfast Brief
ESMO 2019: “In lung cancer, you have to start with the best treatment first”
Prof. Solange Peters, MD, PhD, CHUV Lausanne, about the OS update of the FLAURA trial and disappointing news for immunotherapy in mesothelioma with the PROMISE-meso trial.
Richard Cathomas, MD, of Kantonsspital Graubünden
Abirateron
ESMO 2019: “IMvigor130 will change clinical practice”
Richard Cathomas, MD, of Kantonsspital Graubünden, on this year’s highlights of genitourinary cancers: RADICALS-RT, ARTISTIC and PROfound.